These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis. Ameen M; Alhusayen R; Brandi H; Bøgelund M; Jensen HH; Reitzel SB; Thyssen JP Acta Derm Venereol; 2024 Feb; 104():adv24339. PubMed ID: 38380974 [TBL] [Abstract][Full Text] [Related]
10. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial. Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175 [TBL] [Abstract][Full Text] [Related]
11. Patient and physician preferences for atopic dermatitis injection treatments in Japan. Okubo Y; Ho KA; Fifer S; Fujita H; Oki Y; Taguchi Y J Dermatolog Treat; 2020 Dec; 31(8):821-830. PubMed ID: 31250681 [No Abstract] [Full Text] [Related]
12. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients. Torisu-Itakura H; Anderson P; Piercy J; Pike J; Sakamoto A; Kabashima K Curr Med Res Opin; 2022 Aug; 38(8):1401-1410. PubMed ID: 35787197 [TBL] [Abstract][Full Text] [Related]
13. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Eastman WJ; Malahias S; Delconte J; DiBenedetti D Cutis; 2014 Jul; 94(1):46-53. PubMed ID: 25101344 [TBL] [Abstract][Full Text] [Related]
14. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment. Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110 [TBL] [Abstract][Full Text] [Related]
15. Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States. Feldman SR; Holmen Moeller A; Erntoft Idemyr ST; González JM J Health Econ Outcomes Res; 2017; 4(2):141-157. PubMed ID: 37661952 [No Abstract] [Full Text] [Related]
16. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238 [TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis. Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290 [TBL] [Abstract][Full Text] [Related]
18. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives. Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G Front Psychol; 2023; 14():1062830. PubMed ID: 37425173 [TBL] [Abstract][Full Text] [Related]
19. Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and Germany. Feldman SR; Poulos C; Gilloteau I; Mange B; Boehm K; Boeri M; Naatz M; Augustin M J Dermatolog Treat; 2022 May; 33(3):1511-1520. PubMed ID: 33535847 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]